Altimmune, Inc. Common Stock (ALT) Stock
NASDAQ · ALT
3.25
Fundamentals
Market cap
$632.18M
Price / Earnings ratio
-6.9x
Price / Sales ratio
20329.0x
Price / Book ratio
1.3x
Return on assets
-0.4%
Ex-Dividend date
6 Feb 2017
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Altimmune, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees57
CEOMr. Jerome Benedict Durso
IPO DateOct 6, 2005
HeadquartersGaithersburg, MD
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jerome Benedict Durso | Chairman, CEO & President | 1968 |
| Dr. M. Scot Roberts Ph.D. | Chief Scientific Officer | 1959 |
| Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D. | Chief Medical Officer | 1963 |
| Mr. Gregory L. Weaver CPA, M.B.A. | Chief Financial Officer | 1956 |
| Mr. Andrew Shutterly M.S. | Principal Financial & Accounting Officer and Corporate Controller | 1988 |
| Mr. Bertrand Georges Ph.D. | Chief Technology Officer | — |
| Mr. Luis Sanay C.F.A. | Vice President of Investor Relations | — |
| Mr. Tony Blandin B.S. | Vice President of Quality & Compliance Management | — |
| Ms. Robin E. Abrams J.D. | Chief Legal Officer & Corporate Secretary | 1964 |
| Mr. Raymond M. Jordt M.B.A., M.S. | Chief Business Officer | 1973 |
Fundamentals
Valuation
Market cap$632.18M
Price-to-sales ratio20,329.03
Price-to-book value1.33
Price-earnings ratio-6.90
Return on Equity-43.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio32.62
Earnings Per Share
Earnings Per Share$-0.77
Income Statement
Average volume3,781,806
EBITDA$-88.27M
1 year high (52w)$6.44
1 year low (52w)$2.56
Dividend
Ex dividend date6 Feb 2017
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



